Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06644339 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Remote Multichannel Monitoring of Patients With Chronic DIseAses Using Speech technoLogies Based On Artificial intelliGence

Study acronym: DIALOG
StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated October 16, 2024 (before its estimated February 28, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
I.M. Sechenov First Moscow State Medical University
35 trials monitored
See all monitored trials
Heart Disease
8,786 trials monitored
See 412 trials at risk
Diabetes
5,087 trials monitored
See 222 trials at risk
Heart Failure
1,995 trials monitored
See 111 trials at risk
and 1 more disease
DIALOG is a study to assess the efficacy and safety of remote patient monitoring using virtual operator voice technologies and a business intelligence (BI) system for timely detection, prevention of early complications, worsening of the condition, and other adverse events in patients who have been discharged from the hospital.
Trial Details
NCT Number NCT06644339
Lead Sponsor I.M. Sechenov First Moscow State Medical University
Collaborators: PJSC VimpelCom
Conditions
(from sponsor)		 Heart Failure, Diabetes Mellitus, Arterial Hypertension, Lymphoproliferative Disease, Total Knee Replacement
Related terms Diabetes Mellitus, Heart Failure, Hypertension, Lymphoproliferative Disorders
Enrollment 500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov